Dear sean,
We are excited to announce that the 6th Annual Psychedelic Therapeutics & Drug Development Conference will take place February 26–27, 2026, in New Orleans, LA. This gathering brings together leaders from academia, industry, government, and the investment community to advance the science and commercialization of psychedelic-based therapeutics.
We are now accepting speaker proposals for the 2026 program. If you are conducting groundbreaking research, leading clinical studies, developing new therapies, or shaping the regulatory and market landscape for psychedelic medicines, we invite you to submit your work for consideration.
Conference Topics & Themes:
- Scheduling & patient access
- Clinical trial design and implementation
- Real-world data, outcomes research, and patient experiences
- Biomarker research (fMRI, blood/CSF biomarkers, digital measures)
- Academic research track
- Industry research track
- Regulatory and government affairs
- Market access, HEOR, and reimbursement strategies
- State of the science: emerging data and new directions
- Venture & investment panel
- Legal considerations for psychedelic therapeutics
This event offers a unique platform to present your work, engage with key stakeholders, and contribute to the future of psychedelic medicine.
Submit your speaker proposal today to be part of this important conversation in New Orleans.
Sean Hocking
Source link